Science ❯ Medical Research ❯ Clinical Studies ❯ Drug Efficacy
Researchers say the JAMA Psychiatry interim analysis demands routine eating‑disorder screening before prescribing, with urgent pharmacovigilance as access to GLP‑1 drugs expands.